1. Home
  2. PBH vs COGT Comparison

PBH vs COGT Comparison

Compare PBH & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$59.46

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$39.93

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBH
COGT
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
PBH
COGT
Price
$59.46
$39.93
Analyst Decision
Buy
Buy
Analyst Count
5
13
Target Price
$86.40
$28.08
AVG Volume (30 Days)
454.8K
4.9M
Earning Date
11-06-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.04
N/A
Revenue
$1,110,479,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.69
N/A
P/E Ratio
$14.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.25
$3.72
52 Week High
$90.04
$41.27

Technical Indicators

Market Signals
Indicator
PBH
COGT
Relative Strength Index (RSI) 46.70 87.20
Support Level $57.25 $34.54
Resistance Level $60.35 $36.29
Average True Range (ATR) 1.53 2.77
MACD 0.11 0.76
Stochastic Oscillator 53.58 95.40

Price Performance

Historical Comparison
PBH
COGT

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: